Annual General Meeting in ALK-Abelló A/S held on 13 March 2025

GlobeNewswire

14 Mar

ALK (ALKB:DC / OMX: ALK B / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025.

The Annual General Meeting transacted the following business:

Approval of the annual report 2024 and discharge of the Board of Directors and Board of Management
Resolution not to declare ordinary dividend in accordance with the approved annual report for 2024 and to allocate the profits in accordance with the approved annual report
Adoption of the remuneration report for 2024
Adoption of the remuneration to the Board of Directors for the present year
Re-election of Anders Hedegaard as the Chair of the Board of Directors
Re-election of Lene Skole as the Vice Chair of the Board of Directors
Re-election of Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark and Alan Main to the Board of Directors
PwC Statsautoriseret Revisionspartnerselskab was re-appointed as the company’s auditor in respect of statutory financial reporting as well as sustainability reporting

ALK-Abelló A/S

For further information please contact:

Anders Hedegaard, Chair, tel. +45 4574 7576

About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.

Attachment

Company release_06_25UK_130325_AGM minutes

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/news/2519785273"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2519785273\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2519785273?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-14 01:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2519785273","market":"hk","top_or_hot":-1,"title":"Annual General Meeting in ALK-Abelló A/S held on 13 March 2025","media":"GlobeNewswire","content":"<html><body><p>ALK (<i>ALKB:DC / OMX: ALK B / AKBLF</i>): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025.</p> <p>The Annual General Meeting transacted the following business:</p> <ul><li>Approval of the annual report 2024 and discharge of the Board of Directors and Board of Management</li><li>Resolution not to declare ordinary dividend in accordance with the approved annual report for 2024 and to allocate the profits in accordance with the approved annual report</li><li>Adoption of the remuneration report for 2024</li><li>Adoption of the remuneration to the Board of Directors for the present year</li><li>Re-election of Anders Hedegaard as the Chair of the Board of Directors</li><li>Re-election of Lene Skole as the Vice Chair of the Board of Directors</li><li>Re-election of Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark and Alan Main to the Board of Directors</li><li>PwC Statsautoriseret Revisionspartnerselskab was re-appointed as the company’s auditor in respect of statutory financial reporting as well as sustainability reporting</li></ul> <p><b>ALK-Abelló A/S</b></p> <p><b>For further information please contact:</b></p> <p>Anders Hedegaard, Chair, tel. +45 4574 7576</p> <p><b><i>About ALK</i></b><br/><i>ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net</i><i>.</i></p> <p>\n<strong>Attachment</strong>\n</p>\n<ul>\n<li>\nCompany release_06_25UK_130325_AGM minutes\n</li>\n</ul>\n<br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/Nzc5YTRhMzgtNzU5ZS00YmZhLTk2NGUtZTVlY2Q1NWUyYzQ1LTEwMTM4MDQtMjAyNS0wMy0xMy1lbg==/tiny/ALK-Abello.png\"/></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Annual General Meeting in ALK-Abelló A/S held on 13 March 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnnual General Meeting in ALK-Abelló A/S held on 13 March 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2025-03-14 01:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>ALK (<i>ALKB:DC / OMX: ALK B / AKBLF</i>): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025.</p> <p>The Annual General Meeting transacted the following business:</p> <ul><li>Approval of the annual report 2024 and discharge of the Board of Directors and Board of Management</li><li>Resolution not to declare ordinary dividend in accordance with the approved annual report for 2024 and to allocate the profits in accordance with the approved annual report</li><li>Adoption of the remuneration report for 2024</li><li>Adoption of the remuneration to the Board of Directors for the present year</li><li>Re-election of Anders Hedegaard as the Chair of the Board of Directors</li><li>Re-election of Lene Skole as the Vice Chair of the Board of Directors</li><li>Re-election of Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark and Alan Main to the Board of Directors</li><li>PwC Statsautoriseret Revisionspartnerselskab was re-appointed as the company’s auditor in respect of statutory financial reporting as well as sustainability reporting</li></ul> <p><b>ALK-Abelló A/S</b></p> <p><b>For further information please contact:</b></p> <p>Anders Hedegaard, Chair, tel. +45 4574 7576</p> <p><b><i>About ALK</i></b><br/><i>ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net</i><i>.</i></p> <p>\n<strong>Attachment</strong>\n</p>\n<ul>\n<li>\nCompany release_06_25UK_130325_AGM minutes\n</li>\n</ul>\n<br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/Nzc5YTRhMzgtNzU5ZS00YmZhLTk2NGUtZTVlY2Q1NWUyYzQ1LTEwMTM4MDQtMjAyNS0wMy0xMy1lbg==/tiny/ALK-Abello.png\"/></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.globenewswire.com/news-release/2025/03/13/3042490/0/en/Annual-General-Meeting-in-ALK-Abell%C3%B3-A-S-held-on-13-March-2025.html","article_id":"2519785273","we_media_id":"1016364462","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2519785273","pubTimestamp":1741885560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"GlobeNewswire","introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"summary":"Attachment","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4500":"航空公司","ALK":"阿拉斯加航空集团有限公司","BK4008":"航空公司"},"translate_title":"Alk-AbellóA/S于2025年3月13日举行的股东周年大会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALK":1},"content_text":"ALK (ALKB:DC / OMX: ALK B / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025. The Annual General Meeting transacted the following business: Approval of the annual report 2024 and discharge of the Board of Directors and Board of ManagementResolution not to declare ordinary dividend in accordance with the approved annual report for 2024 and to allocate the profits in accordance with the approved annual reportAdoption of the remuneration report for 2024Adoption of the remuneration to the Board of Directors for the present yearRe-election of Anders Hedegaard as the Chair of the Board of DirectorsRe-election of Lene Skole as the Vice Chair of the Board of DirectorsRe-election of Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark and Alan Main to the Board of DirectorsPwC Statsautoriseret Revisionspartnerselskab was re-appointed as the company’s auditor in respect of statutory financial reporting as well as sustainability reporting ALK-Abelló A/S For further information please contact: Anders Hedegaard, Chair, tel. +45 4574 7576 About ALKALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net. \nAttachment\n\n\n\nCompany release_06_25UK_130325_AGM minutes","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}